How the product works:
Nintedanib is a tyrosine kinase inhibitor that targets pathways involved in fibrosis and tumour angiogenesis. It slows the thickening of lung tissue, reduces inflammation, and inhibits the progression of pulmonary fibrosis. It also has antiproliferative effects on cancer cells.
Recommended for:
Capsules should be taken orally, twice daily approximately 12 hours apart, preferably with food. Duration of treatment is based on the disease progression and physician's judgement.
Contraindications:
Side effects:
